These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

266 related items for PubMed ID: 12476322

  • 1. Dopamine D2S and D2L receptors may differentially contribute to the actions of antipsychotic and psychotic agents in mice.
    Xu R, Hranilovic D, Fetsko LA, Bucan M, Wang Y.
    Mol Psychiatry; 2002; 7(10):1075-82. PubMed ID: 12476322
    [Abstract] [Full Text] [Related]

  • 2. Distinct functions of the two isoforms of dopamine D2 receptors.
    Usiello A, Baik JH, Rougé-Pont F, Picetti R, Dierich A, LeMeur M, Piazza PV, Borrelli E.
    Nature; 2000 Nov 09; 408(6809):199-203. PubMed ID: 11089973
    [Abstract] [Full Text] [Related]

  • 3. Combined alpha 2-adrenergic/D2 dopamine receptor blockade fails to reproduce the ability of clozapine to reverse phencyclidine-induced deficits in prepulse inhibition of startle.
    Ballmaier M, Zoli M, Mazzoncini R, Gennarelli M, Spano F.
    Psychopharmacology (Berl); 2001 Dec 09; 159(1):105-10. PubMed ID: 11797077
    [Abstract] [Full Text] [Related]

  • 4. The D2S and D2L dopamine receptor isoforms are differentially regulated in Chinese hamster ovary cells.
    Zhang LJ, Lachowicz JE, Sibley DR.
    Mol Pharmacol; 1994 May 09; 45(5):878-89. PubMed ID: 7910658
    [Abstract] [Full Text] [Related]

  • 5. Dopamine D2 long receptor-deficient mice display alterations in striatum-dependent functions.
    Wang Y, Xu R, Sasaoka T, Tonegawa S, Kung MP, Sankoorikal EB.
    J Neurosci; 2000 Nov 15; 20(22):8305-14. PubMed ID: 11069937
    [Abstract] [Full Text] [Related]

  • 6. Alterations in D1/D2 synergism may account for enhanced stereotypy and reduced climbing in mice lacking dopamine D2L receptor.
    Fetsko LA, Xu R, Wang Y.
    Brain Res; 2003 Mar 28; 967(1-2):191-200. PubMed ID: 12650980
    [Abstract] [Full Text] [Related]

  • 7. Dopamine D2 receptor-mediated inhibition of dopaminergic neurons in mice lacking D2L receptors.
    Centonze D, Usiello A, Gubellini P, Pisani A, Borrelli E, Bernardi G, Calabresi P.
    Neuropsychopharmacology; 2002 Nov 28; 27(5):723-6. PubMed ID: 12431847
    [Abstract] [Full Text] [Related]

  • 8. Differential contribution of dopamine D2S and D2L receptors in the modulation of glutamate and GABA transmission in the striatum.
    Centonze D, Gubellini P, Usiello A, Rossi S, Tscherter A, Bracci E, Erbs E, Tognazzi N, Bernardi G, Pisani A, Calabresi P, Borrelli E.
    Neuroscience; 2004 Nov 28; 129(1):157-66. PubMed ID: 15489038
    [Abstract] [Full Text] [Related]

  • 9. Effects of spiperone, raclopride, SCH 23390 and clozapine on apomorphine inhibition of sensorimotor gating of the startle response in the rat.
    Swerdlow NR, Keith VA, Braff DL, Geyer MA.
    J Pharmacol Exp Ther; 1991 Feb 28; 256(2):530-6. PubMed ID: 1825226
    [Abstract] [Full Text] [Related]

  • 10. Distinct roles of dopamine D2L and D2S receptor isoforms in the regulation of protein phosphorylation at presynaptic and postsynaptic sites.
    Lindgren N, Usiello A, Goiny M, Haycock J, Erbs E, Greengard P, Hokfelt T, Borrelli E, Fisone G.
    Proc Natl Acad Sci U S A; 2003 Apr 01; 100(7):4305-9. PubMed ID: 12651945
    [Abstract] [Full Text] [Related]

  • 11. L-745,870, a subtype selective dopamine D4 receptor antagonist, does not exhibit a neuroleptic-like profile in rodent behavioral tests.
    Bristow LJ, Collinson N, Cook GP, Curtis N, Freedman SB, Kulagowski JJ, Leeson PD, Patel S, Ragan CI, Ridgill M, Saywell KL, Tricklebank MD.
    J Pharmacol Exp Ther; 1997 Dec 01; 283(3):1256-63. PubMed ID: 9400001
    [Abstract] [Full Text] [Related]

  • 12. Expression of D2 receptor isoforms in cultured neurons reveals equipotent autoreceptor function.
    Jomphe C, Tiberi M, Trudeau LE.
    Neuropharmacology; 2006 Apr 01; 50(5):595-605. PubMed ID: 16412480
    [Abstract] [Full Text] [Related]

  • 13. Paradoxical regulation of dopamine receptors in transfected 293 cells.
    Filtz TM, Artymyshyn RP, Guan W, Molinoff PB.
    Mol Pharmacol; 1993 Aug 01; 44(2):371-9. PubMed ID: 8102783
    [Abstract] [Full Text] [Related]

  • 14. Differential agonist and inverse agonist profile of antipsychotics at D2L receptors coupled to GIRK potassium channels.
    Heusler P, Newman-Tancredi A, Castro-Fernandez A, Cussac D.
    Neuropharmacology; 2007 Mar 01; 52(4):1106-13. PubMed ID: 17239906
    [Abstract] [Full Text] [Related]

  • 15. Long-term haloperidol treatment (but not risperidone) enhances addiction-related behaviors in mice: role of dopamine D2 receptors.
    Carvalho RC, Fukushiro DF, Helfer DC, Callegaro-Filho D, Trombin TF, Zanlorenci LH, Sanday L, Silva RH, Frussa-Filho R.
    Addict Biol; 2009 Jul 01; 14(3):283-93. PubMed ID: 19298320
    [Abstract] [Full Text] [Related]

  • 16. The effects of dopamine and D2 receptor antagonists on pituitary hormone secretion are intact in mice lacking dopamine D2L receptor.
    Xu R, Parlow AF, Wang Y.
    Brain Res; 2002 Jun 07; 939(1-2):95-9. PubMed ID: 12020855
    [Abstract] [Full Text] [Related]

  • 17. Effects of SB-269970, a 5-HT7 receptor antagonist, in mouse models predictive of antipsychotic-like activity.
    Galici R, Boggs JD, Miller KL, Bonaventure P, Atack JR.
    Behav Pharmacol; 2008 Mar 07; 19(2):153-9. PubMed ID: 18332680
    [Abstract] [Full Text] [Related]

  • 18. In vitro and in vivo characterization of F-97013-GD, a partial 5-HT1A agonist with antipsychotic- and antiparkinsonian-like properties.
    Zazpe A, Artaiz I, Innerárity A, Del Olmo E, Castro E, Labeaga L, Pazos A, Orjales A.
    Neuropharmacology; 2006 Jul 07; 51(1):129-40. PubMed ID: 16643965
    [Abstract] [Full Text] [Related]

  • 19. Cholecystokinin2 receptor-deficient mice display altered function of brain dopaminergic system.
    Kõks S, Volke V, Veraksits A, Rünkorg K, Sillat T, Abramov U, Bourin M, Huotari M, Männistö PT, Matsui T, Vasar E.
    Psychopharmacology (Berl); 2001 Nov 07; 158(2):198-204. PubMed ID: 11702094
    [Abstract] [Full Text] [Related]

  • 20. KKHA-761, a potent D3 receptor antagonist with high 5-HT1A receptor affinity, exhibits antipsychotic properties in animal models of schizophrenia.
    Park WK, Jeong D, Cho H, Lee SJ, Cha MY, Pae AN, Choi KI, Koh HY, Kong JY.
    Pharmacol Biochem Behav; 2005 Oct 07; 82(2):361-72. PubMed ID: 16216322
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.